Related Experiment Video
Updated: Jan 9, 2026

Fluorescence Assays for the Study of Mycobacterium tuberculosis Interaction with the Immune Receptor SLAMF1
Published on: February 28, 2025
Synergistic interaction between tuberculosis and depression: Changes in miRNA expression.
Kevser Elçi1, Necmiye Canacankatan1, Cem Yalaza2
1Department of Biochemistry, Faculty of Pharmacy, Mersin University, Mersin, Turkey.
Depression significantly complicates Tuberculosis treatment. This study found increased levels of specific microRNAs (miRNAs) in Tuberculosis patients, suggesting a link between Tuberculosis and Depression (DP) pathology and identifying potential new biomarkers for Tuberculosis.
Area of Science:
- Biochemistry
- Molecular Biology
- Genetics
Background:
- Depression (DP) in Tuberculosis (TB) patients impedes treatment adherence, prolongs infectiousness, and contributes to drug resistance, hindering TB elimination efforts.
- Understanding the complex interplay between TB and DP is crucial for effective TB control strategies.
Purpose of the Study:
- To investigate the expression levels of nine specific microRNAs (miRNAs) associated with Depression pathology in active Tuberculosis patients.
- To evaluate the potential synergy between Tuberculosis and Depression by analyzing miRNA expression patterns.
Main Methods:
- The study involved two groups: active Tuberculosis patients and a healthy control group.
- Real-Time Polymerase Chain Reaction (PCR) was employed to quantify the expression levels of selected miRNAs.
Main Results:
- A statistically significant increase in the expression of miR-128-3p, miR-34a-5p, miR-223-3p, miR-221-3p, miR-24-3p, miR-107, miR-134-5p, and miR-135a was observed in the Tuberculosis patient group compared to the control group (p < 0.05).
- No significant difference in miR-1202 expression levels was found between the two groups (p = 0.169).
Conclusions:
- The elevated expression of miR-128-3p, miR-34a-5p, miR-223-3p, miR-221-3p, and miR-24-3p in TB patients, consistent with previous findings in DP patients, suggests their involvement in the TB-DP synergy.
- miR-24-3p, miR-107, miR-134-5p, and miR-135a show potential as novel biomarker candidates for Tuberculosis detection.
More Related Videos
15:28A Microscopic Phenotypic Assay for the Quantification of Intracellular Mycobacteria Adapted for High-throughput/High-content Screening
Published on: January 17, 2014
09:34An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
Published on: August 16, 2021
Related Concept Videos
MicroRNAs
MicroRNAs
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Depressive Disorders: Etiology
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...